Our Board of Directors has collective responsibility for the long-term success of Vectura. Following our successful merger with Skyepharma, the Board has been working to ensure that we have effective, entrepreneurial and prudent management for the long-term success of the business and that our governance for the enlarged Group facilitates that.

Compliance with the UK Governance Code

Further information regarding our governance at Vectura can be found in our Report and Accounts for the year ended 31 December 2018 available here.

The Audit Committee terms of reference
The Nomination Committee terms of reference
The Remuneration Committee terms of reference
Remuneration Policy approved 2017
Articles of Association
Schedule of Matters Reserved for the Board

2018 AGM Votes

Statement under s.430(2B) Companies Act 2006

A copy of our Modern Slavery Statement can be found here.